The aim is to test the efficacy of AIM2ACT and long-term maintenance of treatment effects in a fully-powered randomized controlled trial with 160 early adolescents with poorly controlled persistent asthma, ages 12-15 years, and a caregiver
- Investigators
- Sreekala Prabhakaran, David Fedele
- Status
- Accepting Candidates
- Ages
- 12 Years - 70 Years
- Sexes
- All